Episode 29

Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. 

CME information and select publications here.

All Episodes Previous Episode

About the Podcast

Show artwork for Lung Cancer Update
Lung Cancer Update
This series bridges the gap between research and patient care by providing medical oncologists and hematologists ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

Listen for free